Business Segments · Segment adjusted EBITDA

Medline Brand — Segment adjusted EBITDA

Medline, Inc. Medline Brand — Segment adjusted EBITDA decreased by 7.8% to $765.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 7.8%, from $830.00M to $765.00M. This decline may warrant attention — for this metric, higher values are generally preferred.

Analysis

StatementSegment
CategoryProfitability
SignalHigher is better
VolatilityModerate
First reportedQ1 2023
Last reportedQ1 2026

How to read this metric

An increase indicates improved operational efficiency or higher margins, while a decrease suggests rising costs or margin compression.

Detailed definition

Measures the operational profitability of the Medline Brand segment by excluding interest, taxes, depreciation, amortiza...

Peer comparison

Standard 'Adjusted EBITDA' metric used across the healthcare manufacturing industry to compare operational performance.

Metric ID: mdln_segment_medline_brand_segment_adjusted_ebitda

Historical Data

10 periods
 Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q1 '26
Value$676.00M$676.00M$676.00M$676.00M$817.25M$817.25M$817.25M$817.25M$830.00M$765.00M
QoQ Change+0.0%+0.0%+0.0%+20.9%+0.0%+0.0%+0.0%+1.6%-7.8%
YoY Change+20.9%+20.9%+20.9%+20.9%+1.6%-7.8%
Range$676.00M$830.00M
CAGR+5.7%
Avg YoY Growth+12.9%
Median YoY Growth+20.9%

Frequently Asked Questions

What is Medline, Inc. 's medline brand — segment adjusted ebitda?
Medline, Inc. (MDLN) reported medline brand — segment adjusted ebitda of $765.00M in Q1 2026.
How has Medline, Inc. 's medline brand — segment adjusted ebitda changed year-over-year?
Medline, Inc. 's medline brand — segment adjusted ebitda decreased by 7.8% year-over-year, from $830.00M to $765.00M.
What does medline brand — segment adjusted ebitda mean?
A measure of the segment's core operational profitability before accounting for financing, taxes, and non-cash expenses.